230 related articles for article (PubMed ID: 23233043)
1. Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.
Wu B; Zhou H; Hu L; Mu Y; Wu Y
Tumour Biol; 2013 Apr; 34(2):837-46. PubMed ID: 23233043
[TBL] [Abstract][Full Text] [Related]
2. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.
Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X
Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939
[TBL] [Abstract][Full Text] [Related]
3. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.
Hu L; Xia L; Zhou H; Wu B; Mu Y; Wu Y; Yan J
Tumour Biol; 2013 Oct; 34(5):2573-81. PubMed ID: 23616010
[TBL] [Abstract][Full Text] [Related]
4. [Role of NF-κB in factor VIIa-induced proliferation and migration of colon cancer cell line SW620 cells].
Guo DL; Zhou H; Wu Y; Zhou F; Zhang XM; Xu GY; Wen HP
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):649-53. PubMed ID: 22340043
[TBL] [Abstract][Full Text] [Related]
5. Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-κB signaling pathways.
Wu Y; Zhang X; Zhou H; Chen D; Xie H; Mu Y; Wu B; Yan J
Cancer Invest; 2013 Jan; 31(1):7-16. PubMed ID: 23170789
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro.
Zhou F; Zhou H; Wang T; Mu Y; Wu B; Guo DL; Zhang XM; Wu Y
Acta Pharmacol Sin; 2012 Jan; 33(1):120-6. PubMed ID: 22101170
[TBL] [Abstract][Full Text] [Related]
7. Effects of calcium signaling on coagulation factor VIIa-induced proliferation and migration of the SW620 colon cancer cell line.
Wu Y; Wang J; Zhou H; Yu X; Hu L; Meng F; Jiang S
Mol Med Rep; 2014 Dec; 10(6):3021-6. PubMed ID: 25323578
[TBL] [Abstract][Full Text] [Related]
8. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of the mechanisms of coagulation factor VIIa-induced colon cancer SW620 cell proliferation and migration].
Shi WX; Zhou H; Li N; Huang HL; Zhou BC
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):485-9. PubMed ID: 19950693
[TBL] [Abstract][Full Text] [Related]
10. Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2.
Zhou B; Zhou H; Ling S; Guo D; Yan Y; Zhou F; Wu Y
Oncol Rep; 2011 Feb; 25(2):503-11. PubMed ID: 21152870
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor-factor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation.
Zhou H; Shi W; Zhou B; Guo D; Wang T
Mol Med Rep; 2010; 3(2):269-74. PubMed ID: 21472232
[TBL] [Abstract][Full Text] [Related]
12. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
15. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
16. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.
Fan L; Yotov WV; Zhu T; Esmailzadeh L; Joyal JS; Sennlaub F; Heveker N; Chemtob S; Rivard GE
J Thromb Haemost; 2005 May; 3(5):1056-63. PubMed ID: 15869604
[TBL] [Abstract][Full Text] [Related]
19. Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.
Zhu T; Mancini JA; Sapieha P; Yang C; Joyal JS; Honoré JC; Leduc M; Zaniolo K; Hardy P; Shao Z; Fan L; Hou X; Rivard GE; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R577-85. PubMed ID: 21160057
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J
Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]